Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. VINGE ADVISES ANICURA IN CONNECTION WITH THE ACQUISITION OF DJURSKUKHUSET I JÄGARVALLEN
Mandate

VINGE ADVISES ANICURA IN CONNECTION WITH THE ACQUISITION OF DJURSKUKHUSET I JÄGARVALLEN

November 18, 2014

Vinge has advised AniCura in connection with the acquisition of Djursjukhuset i Jägarvallen, the oldest veterinary clinic in the county of Östergötland. The merger entails that AniCura has broadened its base of veterinary and medical facilities for pet owners in the region. AniCura is a leader in advanced veterinary care for dogs, cats and other companion animals. The company was founded on the notion of combining resources to provide better veterinary care. Established in 2011, AniCura is the first merger of companion animal hospitals in the Nordic region, and is currently the only Nordic veterinary care group exclusively focused on companion animals.

Vinge’s team consisted of responsible partner Jonas Bergström together with, among others, associates Gustav Jönsson and Ulrika Andersson.   

Related

Vinge advises Meribel Pharma Solutions

 Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

 Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025

Vinge has advised Sveafastigheter in connection with its uplisting to Nasdaq Stockholm

 Vinge has advised Sveafastigheter AB (publ) in connection with its list change from Nasdaq First North Premier Growth Market to Nasdaq Stockholm. The prospectus was published on 13 June 2025 and the trading on Nasdaq Stockholm commenced on 18 June 2025.
June 18, 2025